iSonea expands board expertise with new director appointments – Proactive Investors Australia


Proactive Investors Australia

iSonea expands board expertise with new director appointments
Proactive Investors Australia
iSonea recently reached an important milestone with the start of its first large US post-market study of its WheezoMeterâ„¢ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too
iSonea debuts asthma app platformFierceMobileHealthcare (press release)

all 2 news articles »

View full post on asthma – Google News

Dr. Lynn M. Taussig Named Chairman of iSonea’s Medical Advisory Board – MarketWatch (press release)

Dr. Lynn M. Taussig Named Chairman of iSonea's Medical Advisory Board
MarketWatch (press release)
The mission of the MAB is to advise iSonea on clinical studies related to the commercial development of its Acoustic Respiratory Monitoring(TM) (ARM) devices and mobile health applications for the management of asthma and related respiratory disorders.

and more »

View full post on asthma – Google News